期刊文献+

2007-2011年国家避孕药品不良反应报告关联性评价分析 被引量:3

Analysis of Relationship Evaluation of State Contraceptives Adverse Drug Reaction Reports from 2007 to 2011
原文传递
导出
摘要 目的:提高我国避孕药品不良反应(ADR)监测评价水平。方法:对国家人口计生委计划生育ADR监测中心2007-2011年收集到的1572例避孕药品ADR报告进行关联性评价。结果:1572例ADR报告以"很可能"的一般报告居多,有1029例,占66.00%,主要涉及口服避孕药(567例)和皮下埋植剂(415例);ADR评价为"很可能"的口服避孕药排序靠前的ADR类型主要为月经问题、血压升高等。结论:对个例报告进行关联性评价是提取可靠信号的基础和重要内容,因而需进一步提升基层业务人员的报告意识和关联性评价水平。 OBJECTIVE: To improve the level of contraceptives adverse drug reaction (ADR) monitoring in China. METH- ODS: 'The relationship of 1 572 contraceptives ADR reports collected by State Contraceptives Adverse Reaction Surveillance Center (SCARS) from 2007 to 2011 were evaluated. RESULTS: The majority of the total 1 572 ADR cases were the "vary probable" gen- eral reports, and there were 1 029 cases, accounting for 66.00%, mainly related to the oral contraceptives (567 cases) and subcuta- neous implants (415 cases). The types of ADR, which took up the top in the list of "very probable" oral contraceptives, were mainly problem of menstruation, increase of blood pressure, etc. CONCLUSIONS: It is the basic and important content to extract reliable signals by evaluating the relationship of case report, which is suggested to enhance the awareness of ADR reporting and im- prove the level of ADR relationship assessment of the professional staffs in primary areas.
出处 《中国药房》 CAS CSCD 2013年第14期1303-1305,共3页 China Pharmacy
基金 "十一五"国家科技支撑计划课题"避孕药具上市后监测和风险再评价研究"(No.2006BAI15B07) 江苏省科技厅项目"避孕药具监测数据挖掘与风险评价模型研究特色业务建设"(No.BM2012062)
关键词 避孕药品 不良反应 关联性评价 Contraceptive Adverse drug reaction Relationship evaluation
  • 相关文献

参考文献6

二级参考文献41

  • 1王永发,周利锋,徐晋勋.避孕药具不良反应监测与评价考察报告[J].中国计划生育学杂志,2005,13(6):333-336. 被引量:2
  • 2张京航,张俊,张黎明.北京市2004年《药品不良反应/事件报告表》质量分析[J].中国药物警戒,2005,2(4):204-206. 被引量:11
  • 3许梅林,沈海屏,韦相才.我国开展避孕药具不良反应监测的研究与思考[J].中国计划生育学杂志,2006,14(9):519-522. 被引量:2
  • 4朱昊平,程利南.紧急避孕药作为非处方药的现状及展望[J].中国计划生育学杂志,2007,15(6):375-377. 被引量:3
  • 5International Conference on Harmonization on Technical Requirements of Pharmaceuticals for Human Use.Topic 2A Note for Guidance on Clinical Safety Data Management:Definitions and Standards for Expedited Reporting,CPMP/[CH/377/95[M].London:Buropcan Agency for the Evaluation of Medicinal Products,1994.
  • 6CIOMS Working Group V.Current Challenges in Pharmacovigilance:Pragmatic Approaches:Report of CIOMS Working Group V[R].Council for International Organizations of Medical Sciences,Geneva,2001.
  • 7International Conference on Harmonization on Technical Requirements of Pharmaceuticals for Human Use.Topic 2A Note for Guidance on Clinical Safety Data Management:Definitions and Standards for Expedited Reporting,CPMP/ICH/377/95[R].London:European Agency for the Evaluation of Medicinal Products,1994.
  • 8WHO.Adverse Reaction Terminology Critical Term List,WHO Collaborating Center for International Drug Monitoring,Uppsala,Sweden[EB/OL].[2009-02-02].http//www.who-umc.org.
  • 9Shakir SAW.Causality and correlation in pharmacovigilance.In:Talbot J,Waller P(ed).Stephens'Detection of New Adverse Drug Reactions[J].2004(5):329-343.
  • 10Meyboom R H B,Hekster Y A,Egberts A C G,et al.Causal or Casual?The role of causality assessment in pharmacovigilance[J].Drug Safety 1997;17(6):374-389.

共引文献158

同被引文献36

  • 1杜文民,王永铭,程能能.药物不良反应的判定与其研究方法(续一)[J].中国药物警戒,2004,1(2):17-20. 被引量:16
  • 2吴舒梅,胡文彬,杨任民.二巯丙磺钠的过敏反应及其治疗方法[J].安徽中医学院学报,2006,25(6):45-47. 被引量:11
  • 3黄宇虹,张伯礼.单一事件药物不良反应的因果关系评价[J].中国临床药理学与治疗学,2007,12(6):697-699. 被引量:4
  • 4国家药品不良反应监测中心 国家食品药品监督管理局药品评价中心编译.WHO药品不良反应术语集[M].北京:中国医药科学技术出版社,2003..
  • 5田少雷,邵庆翔.药物临床试验与GCP实用指南[M].2版.北京:北京大学医学出版社,2010:31.
  • 6SACKETT DL. Clinical Epidemilogy [ M ]. 2nd. Boston: Little, Brown and Company, 1991:297 - 299.
  • 7The Uppsala Monitoring Centre(the UMC). Safety monitoring of medicinal products:guidelines for setting up and running a phar- macovigilance center[ EB/OL]. [ 2013 - 11 - 15 ]. http ://apps. who. int/medicinedocs/en/d/Jh2934e/15, html.
  • 8EDWARDS IR, BIRIELL C. Harmonisation in pharmacovigi- lance[ J]. Drug Safety,1994,10(2) :93 -102.
  • 9BEGAUD B, EVREUX JC, JOUGLARD J, et al. Unexpected ortoxic drug reaction assessment (imputation). Actualisation of the method used in France[ J]. Therapie, 1985,40 : 111 - 118.
  • 10MEYBOOM RH, HEKSTER YA, EGBERTS AC, et al. Causal or casual? The role of causality assessment in pharmacovigilance [J]. Drug Safety,1997,17(6) :374 -389.

引证文献3

二级引证文献170

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部